Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|August 26, 2022
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance studyAlberto Picca, Cristina Birzu, Giulia Berzero, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 26, 2019
In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical settingValeria Cuccarini, Luigi Antelmi, Bianca Pollo, et al.
Quantitative Imaging in Medicine and Surgery|November 30, 2017
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitisCarla Schettino, Ferdinando Caranci, Giacomo Lus, et al.
Cancer Research|November 3, 2006
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomasSerena Pellegatta, Pietro Luigi Poliani, Daniela Corno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 17, 2023
CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorderValentina Pieri, Davide Gusmeo Curti, Rosina Paterra, et al.
International Journal of Cancer|November 13, 2018
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastomaCristina Corbetta, Natalia Di Ianni, Maria Grazia Bruzzone, et al.
Oncogene|May 9, 2003
The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell linesAlessandro Beghini, Ivana Magnani, Gaia Roversi, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2020
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patientElena Anghileri, Natalia Di Ianni, Rosina Paterra, et al.
Cancers|March 10, 2022
Innovating Strategies and Tailored Approaches in Neuro-OncologyAlberto Picca, David Guyon, Orazio Santo Santonocito, et al.
Genes|June 25, 2020
Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 PatientsDonatella Bianchessi, Maria Cristina Ibba, Veronica Saletti, et al.
Pageof 17